Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8846639 Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Andrew M. Siwkowski0

Eric E. Swayze0

Date of Patent

September 30, 2014

0

Patent Application Number

129361560

Date Filed

April 3, 2009

0

Patent Citations Received

US Patent 12102687 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

0

US Patent 11911484 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

0

US Patent 11931421 Muscle targeting complexes and formulations for treating myotonic dystrophy

0

US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

0

US Patent 12018087 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject

0

US Patent 12060558 Methods and compositions for treatment of cholesteryl ester storage disease

0

US Patent 11787869 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

US Patent 11788089 Compositions and methods for modulating MECP2 expression

...

Patent Primary Examiner

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8846639 Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool